Oncogenic PIK3CA mutations occur in epidermal nevi and seborrheic keratoses with a characteristic mutation pattern

Proceedings of the National Academy of Sciences of the United States of America

Volumn 104, Issue 33, 2007, Pages 13450-13454

  Hafner, Christian ^a   López Knowles, Elena ^b   Luis, Nuno M ^b   Toll, Agustí ^c   Baselga, Eulàlia ^d   Fernández Casado, Alex ^c   Hernández, Silvia ^e   Ribé, Adriana ^d   Mentzel, Thomas ^f   Stoehr, Robert ^a   Hofstaedter, Ferdinand ^a   Landthaler, Michael ^a   Vogt, Thomas ^a   Pujol, Ramòn M ^c   Hartmann, Arndt ^a,g   Real, Francisco X ^b,e,h  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^c HOSPITAL DEL MAR   (Spain)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^e UNIVERSITAT POMPEU FABRA   (Spain)

^f Dermatopathologische Gemeinschaftspraxis   (Germany)

^g UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^h Centro Nacional de Investigaciones Oncológicas   (Spain)

Author keywords

Benign tumor; Oncogene; Senescence; Skin

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 3; PHOSPHATIDYLINOSITOL 3 KINASE;

ALPHA CHAIN; AMINO ACID SUBSTITUTION; ARTICLE; BLADDER TUMOR; EXON; FETUS DEVELOPMENT; GENE MUTATION; HUMAN; HUMAN CELL; KERATINOCYTE; NEVUS; ONCOGENE; PRECANCER; PRIORITY JOURNAL; SEBORRHEIC KERATOSIS; SOMATIC MUTATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; HUMANS; KERATOSIS, SEBORRHEIC; MUTATION; NEVUS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3;

EID: 34548069945     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0705218104     Document Type: Article

References (42)

1. Cantley LC (2002) Science 296:1655-1657.
2. Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB (2005) Nat Rev Drug Discov 4:988-1004.
3. Kang S, Denley A, Vanhaesebroeck B, Vogt PK (2006) Proc Natl Acad Sci USA 103:1289-1294
4. Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S, Yan H, Gazdar A, Powell SM, Riggins GJ, et al. (2004) Science 304:554.
5. Karakas B, Bachman KE, Park BH (2006) Br J Cancer 94:455-459.
6. Bader AG, Kang S, Zhao L, Vogt PK (2005) Nat Rev Cancer 5:921-929.
7. Bader AG, Kang S, Vogt PK (2006) Proc Natl Acad Sci USA 103:1475-1479.
8. Happle R, Rogers M (2002) Adv Dermatol 18:175-201.
9. Yeatman JM, Kilkenny M, Marks R (1997) Br J Dermatol 137:411-414.
10. Hafner C, van Oers JM, Vogt T, Landthaler M, Stoehr R, Blaszyk H, Hofstaedter F, Zwarthoff EC, Hartmann A (2006) J Clin Invest 116:2201-2207.
11. Logie A, Dunois-Larde C, Rosty C, Levrel O, Blanche M, Ribeiro A, Gasc JM, Jorcano J, Werner S, Sastre-Garau X, et al. (2005) Hum Mol Genet 14:1153-1160.
12. Cappellen D, De Oliveira C, Ricol D, de Medina S, Bourdin J, Sastre-Garau X, Chopin D, Thiery JP, Radvanyi F (1999) Nat Genet 23:18-20.
13. Chesi M, Nardini E, Brents LA, Schrock E, Ried T, Kuehl WM, Bergsagel PL (1997) Nat Genet 16:260-264.
14. Vajo Z, Francomano CA, Wilkin DJ (2000) Endocr Rev 21:23-39.
15. Naski MC, Wang Q, Xu J, Ornitz DM (1996) Nat Genet 13:233-237.
16. Hernandez S, Toll A, Baselga E, Ribe A, Azua-Romeo J, Pujol RM, Real FX (2007) J Invest Dermatol 12:1064-1066.
17. Hafner C, van Oers JM, Hartmann A, Landthaler M, Stoehr R, Blaszyk H, Hofstaedter F, Zwarthoff EC, Vogt T (2006) J Invest Dermatol 126:2404-2407.
18. Hafner C, Hartmann A, Real FX, Hofstaedter F, Landthaler M, Vogt T (2007) J Invest Dermatol 127:1883-1885.
19. Hafner C, Vogt T, Hartmann A (2006) Cell Cycle 5:2723-2728.
20. Schlessinger J (2004) Science 306:1506-1507.
21. Eswarakumar VP, Lax I, Schlessinger J (2005) Cytokine Growth Factor Rev 16:139-149.
22. Billerey C, Chopin D, Aubriot-Lorton MH, Ricol D, Gil Diez de Medina S, Van Rhijn B, Bralet MP, Lefrere-Belda MA, Lahaye JB, Abbou CC, et al. (2001) Am J Pathol 158:1955-1959.
23. van Rhijn BW, van der Kwast TH, Vis AN, Kirkels WJ, Boeve ER, Jobsis AC, Zwarthoff EC (2004) Cancer Res 64:1911-1914.
24. Jebar AH, Hurst CD, Tomlinson DC, Johnston C, Taylor CF, Knowles MA (2005) Oncogene 24:5218-5225.
25. Hernandez S, Lopez-Knowles E, Lloreta J, Kogevinas M, Amoros A, Tardon A, Carrato A, Serra C, Malats N, Real FX (2006) J Clin Oncol 24:3664-3671.
26. Lopez-Knowles E, Hernandez S, Malats N, Kogevinas M, Lloreta J, Carrato A, Tardon A, Serra C, Real FX (2006) Cancer Res 66:7401-7404.
27. Barry EL, Baron JA, Grau MV, Wallace K, Haile RW (2006) Cancer 106:1036-1040.
28. Spring KJ, Zhao ZZ, Karamatic R, Walsh MD, Whitehall VL, Pike T, Simms LA, Young J, James M, Montgomery GW, et al. (2006) Gastroenterology 131:1400-1407.
29. Thomas NE (2006) Melanoma Res 16:97-103.
30. Gymnopoulos M, Elsliger MA, Vogt PK (2007) Proc Natl Acad Sci USA 104:5569-5574.
31. van Rhijn BW, van Tilborg AA, Lurkin I, Bonaventure J, de Vries A, Thiery JP, van der Kwast TH, Zwarthoff EC, Radvanyi F (2002) Eur J Hum Genet 10:819-824.
32. Vineis P, Malats N, Porta M, Real FX (1999) Mutat Res 436:185-194.
33. Nakamura H, Hirota S, Adachi S, Ozaki K, Asada H, Kitamura Y (2001) J Invest Dermatol 116:506-510.
34. Legeai-Mallet L, Benoist-Lasselin C, Munnich A, Bonaventure J (2004) Bone 34:26-36.
35. Collado M, Serrano M (2005) Cell Cycle 4:1722-1724.
36. Sarkisian CJ, Keister BA, Stairs DB, Boxer RB, Moody SE, Chodosh LA (2007) Nat Cell Biol 9:493-505.
37. Courtois-Cox S, Genther Williams SM, Reczek EE, Johnson BW, McGillicuddy LT, Johannessen CM, Hollstein PE, MacCollin M, Cichowski K (2006) Cancer Cell 10:459-472.
38. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW (1997) Cell 88:593-602.
39. Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, van der Horst CM, Majoor DM, Shay JW, Mooi WJ, Peeper DS (2005) Nature 436:720-724.
40. Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, Niki M, Koutcher JA, Scher HI, Ludwig T, Gerald W, et al. (2005) Nature 436:725-730.
41. Mallette FA, Gaumont-Leclerc MF, Ferbeyre G (2007) Genes Dev 21:43-48.
42. van Oers JM, Lurkin I, van Exsel AJ, Nijsen Y, van Rhijn BW, van der Aa MN, Zwarthoff EC (2005) Clin Cancer Res 11:7743-7748.